Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor
Main Authors: | Laura Grohs, Linhan Cheng, Saskia Cönen, Bassam G. Haddad, Astrid Bülow, Idil Toklucu, Lisa Ernst, Jannis Körner, Günther Schmalzing, Angelika Lampert, Jan-Philipp Machtens, Ralf Hausmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1225522/full |
Similar Items
-
Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor
by: Laura Grohs, et al.
Published: (2023-03-01) -
An overview of analgesics: NSAIDs, paracetamol, and topical analgesics
by: R. Van Rensburg, et al.
Published: (2019-03-01) -
Non-ulcer dyspepsia associated with NSAID intake: possibility of antacid drugs application
by: A. E. Karateev, et al.
Published: (2003-04-01) -
The Potential Preventive and Therapeutic Roles of NSAIDs in Prostate Cancer
by: Hossein Maghsoudi, et al.
Published: (2023-11-01) -
Modern opportunities for treatment and prevention of NSAID-induced enteropathies
by: I. A. Viktorova, et al.
Published: (2020-05-01)